Italia markets closed
Dow Jones
37.713,88 -39,43 (-0,10%) Nasdaq
15.622,22 -61,15 (-0,39%) Nikkei 225
38.079,70 +117,90 (+0,31%) EUR/USD
1,0652 -0,0023 (-0,21%) Bitcoin EUR
59.461,94 +2.475,08 (+4,34%) CMC Crypto 200
885,54 0,00 (0,00%)
DaVita Inc. (DVA)
NYSE - Nasdaq Prezzo in tempo reale. Valuta in USD.
Aggiungi a watchlist
In data: 01:38PM EDT. Mercato aperto.
| Chiusura precedente | 127,64 |
| Aperto | 127,60 |
| Denaro | 125,68 x 1000 |
| Lettera | 125,88 x 1200 |
| Min-Max giorno | 125,71 - 128,57 |
| Intervallo di 52 settimane | 71,51 - 141,54 |
| Volume | |
| Media Volume | 841.217 |
| Capitalizzazione | 11,021B |
| Beta (5 anni mensile) | 1,05 |
| Rapporto PE (ttm) | 17,01 |
| EPS (ttm) | 7,42 |
| Prossima data utili | 02 mag 2024 |
| Rendimento e dividendo (futuro) | N/D (N/D) |
| Data ex dividendo | N/D |
| Stima target 1A | 132,00 |
GlobeNewswireNuwellis Inc. Announces Pilot Agreement With DaVita Inc.
Supply Agreement to Pilot Ultrafiltration Therapy Services Offering in Select MarketsMINNEAPOLIS, June 20, 2023 (GLOBE NEWSWIRE) -- Nuwellis, Inc. (Nasdaq: NUWE), a medical technology company focused on transforming the lives of people with fluid overload, today announced it has entered into a Supply and Collaboration Agreement with DaVita Inc. (NYSE: DVA) to pilot Aquadex ultrafiltration therapy to treat adult patients with congestive heart failure and related conditions within select U.S. mark
© 2024 Yahoo. Tutti i diritti riservati.